Overview of Inflammation: Definition, Types, Causes, Benefits and Pathologic Consequences

Learning outcomes

• Define inflammation and explain why vascularised tissues are required for a classic inflammatory response.
• Distinguish acute, chronic, granulomatous, serous, fibrinous, suppurative and systemic inflammation.
• List infectious, physical, chemical, immune, necrotic and metabolic causes.
• Explain the protective benefits and the mechanisms of inflammatory tissue damage.
• Describe the sequence from recognition to mediator release, vascular change, leukocyte recruitment, clearance and resolution/repair.
• Recognise local cardinal signs and systemic acute-phase responses.
• Apply the framework to sepsis, anaphylaxis, trauma, autoimmune disease and chronic inflammatory conditions.

1. Definition and essential components

Inflammation is a response of living, vascularised tissue involving:

1. Recognition: sensors detect pathogens (PAMPs) or tissue damage (DAMPs).
2. Vascular reaction: arteriolar dilation, increased endothelial permeability and altered blood flow.
3. Cell recruitment: leukocytes leave the circulation, migrate to the focus and become activated.
4. Elimination: microbes, toxins and dead cells are neutralised or removed.
5. Termination and repair: mediators decline, debris is cleared and tissue returns toward homeostasis or forms scar.

Avascular tissues may show immune or degenerative responses but cannot mount the complete vascular-leukocyte sequence without adjacent vessels.

2. Why inflammation is beneficial

Benefit	How it helps	Clinical example
Containment	Fibrin, oedema and leukocytes limit spread of microbes or toxins.	Abscess wall limits bacterial infection.
Microbial killing	Neutrophils, macrophages, complement and antibodies destroy pathogens.	Neutrophil killing of pyogenic bacteria.
Removal of debris	Phagocytes clear necrotic cells and foreign material.	Macrophages remove infarcted tissue.
Initiation of repair	Growth factors stimulate angiogenesis, fibroblasts and re-epithelialisation.	Granulation tissue in a healing wound.
Systemic coordination	Fever, acute-phase proteins and leukocytosis support host defence.	Fever and CRP rise during infection.

3. When inflammation becomes harmful

• Excessive intensity: cytokine storm, anaphylaxis, acute respiratory distress and septic shock.
• Mis-targeting: autoimmunity, immune-complex vasculitis and inflammatory bowel disease.
• Persistence: chronic inflammation causes fibrosis, organ remodelling and malignancy risk.
• Inappropriate timing: inflammation after reperfusion or trauma expands tissue injury.
• Failure to resolve: retained microbes, foreign bodies or defective efferocytosis maintain the response.

4. Causes of inflammation

Cause	Examples	Dominant signals
Infections	Bacteria, viruses, fungi, parasites and prions.	PAMPs, complement, cytokines, inflammasomes.
Necrosis/tissue injury	Infarction, trauma, burns, crush injury and pancreatitis.	DAMPs, ATP, HMGB1, mitochondrial DNA.
Physical agents	Heat, cold, radiation, pressure, electricity and ultraviolet light.	Cell injury, ROS and DAMPs.
Chemicals/toxins	Corrosives, irritants, drugs, smoke and pollutants.	Direct injury, oxidative stress and immune activation.
Immune reactions	Autoantibodies, T cells, immune complexes and allergic responses.	Complement, Fc receptors, cytokines, mast-cell mediators.
Foreign bodies	Splinters, sutures, crystals, dust and prosthetic material.	Macrophages, giant cells and persistent pattern-recognition signals.
Metabolic stress	Urate crystals, cholesterol crystals, obesity and insulin resistance.	NLRP3 inflammasome, adipokines and low-grade cytokines.

5. Acute and chronic inflammation

Feature	Acute inflammation	Chronic inflammation
Onset	Minutes to hours.	Days to years.
Dominant cells	Neutrophils early; mast cells and platelets contribute.	Macrophages, lymphocytes and plasma cells.
Vascular response	Prominent exudation and oedema.	Less dramatic but persistent angiogenesis and remodelling.
Tissue outcome	Resolution, abscess, scar or progression.	Destruction, fibrosis, angiogenesis and ongoing repair.
Typical causes	Trauma, bacterial infection, early allergic reaction.	Tuberculosis, autoimmune disease, chronic viral infection, atherosclerosis.

Acute and chronic inflammation can coexist. A chronic lesion may contain acute flares, and unresolved acute inflammation can transition into chronic inflammation.

6. Recognition of danger

6.1 PAMPs and pattern-recognition receptors

Pathogen-associated molecular patterns include lipopolysaccharide, peptidoglycan, flagellin and viral nucleic acids. Toll-like receptors, NOD-like receptors, RIG-I-like receptors and C-type lectins detect them on immune cells, epithelium and endothelium.

6.2 DAMPs

Damage-associated molecular patterns include extracellular ATP, HMGB1, mitochondrial DNA, uric acid crystals, heat-shock proteins and exposed phospholipids. They activate sterile inflammation after infarction, trauma, surgery and crystal disease.

6.3 Inflammasomes

NLRP3 and related inflammasomes activate caspase-1, which matures IL-1β and IL-18 and may induce pyroptosis. Inflammasomes link infection, cellular stress, cholesterol crystals, silica and metabolic disease to inflammation.

7. The inflammatory sequence

1. Recognition: resident macrophages, mast cells, dendritic cells and epithelial cells detect danger.
2. Mediator release: histamine, prostaglandins, leukotrienes, complement fragments, cytokines and chemokines are produced.
3. Vasodilation: arterioles dilate, increasing blood flow and producing warmth/redness.
4. Permeability increase: endothelial gaps or injury permit protein-rich exudate and leukocytes to leave vessels.
5. Stasis: plasma loss concentrates red cells and slows flow; leukocytes move to the endothelial margin.
6. Leukocyte recruitment: rolling, adhesion, transmigration and chemotaxis bring cells to the focus.
7. Activation: phagocytes ingest and kill microbes, release enzymes and produce ROS.
8. Termination: anti-inflammatory mediators, efferocytosis, lymphatic drainage and repair resolve the response.

8. Local clinical signs

Sign	Mechanism	Clinical observation
Rubor (redness)	Arteriolar dilation and increased blood flow.	Red skin around a wound.
Calor (heat)	Increased blood flow and systemic/local temperature rise.	Warm, tender joint.
Tumor (swelling)	Protein-rich exudate and cellular infiltration.	Oedema or joint effusion.
Dolor (pain)	Bradykinin, prostaglandins, pressure and nerve sensitisation.	Tenderness and pain on movement.
Functio laesa (loss of function)	Pain, swelling, tissue destruction and altered organ physiology.	Reduced joint movement or impaired organ function.

9. Exudate, transudate and oedema

Feature	Exudate	Transudate
Cause	Inflammatory endothelial permeability.	Hydrostatic or oncotic imbalance without primary inflammation.
Protein	High.	Low.
Cells	Often present.	Few cells.
Examples	Pneumonia, cellulitis, inflammatory effusion.	Heart failure, cirrhosis, nephrotic syndrome.

Fibrin-rich exudate can organise into scar if not removed. Purulent exudate contains neutrophils, necrotic debris and often bacteria.

10. Inflammatory mediators: functional map

Mediator	Main source	Important effect
Histamine	Mast cells, basophils, platelets.	Rapid arteriolar dilation and venular permeability.
Prostaglandins	Leukocytes, endothelium and mast cells.	Pain, fever, vasodilation and platelet effects.
Leukotrienes	Leukocytes and mast cells.	Bronchoconstriction, permeability and chemotaxis.
Bradykinin	Plasma kinin system.	Pain, vasodilation and permeability.
Complement C3a/C5a	Plasma cascade.	Mast-cell activation, chemotaxis and opsonisation.
TNF, IL-1, IL-6	Macrophages, endothelium and lymphocytes.	Endothelial activation, fever, acute-phase response and systemic inflammation.
Chemokines	Leukocytes, endothelium and stromal cells.	Directed leukocyte recruitment.
NO	Endothelium and macrophages.	Vasodilation, microbial killing and hypotension when excessive.
ROS/proteases	Neutrophils and macrophages.	Microbial killing but collateral tissue damage.
Lipoxins/resolvins	Leukocytes and other cells.	Resolution, reduced neutrophil recruitment and enhanced clearance.

11. Benefits versus harmful consequences

Protective effect	Potential harm when excessive or persistent
Contains infection with fibrin and oedema.	Oedema compromises airways, brain or microcirculation.
Leukocytes kill microbes.	ROS and proteases destroy viable host tissue.
Fever and acute-phase proteins support defence.	High fever, dehydration, delirium and increased metabolic demand.
Fibrin and growth factors initiate repair.	Fibrosis, adhesions and organ stiffness.
Immune memory develops.	Autoimmune disease and chronic inflammatory injury.
Thrombosis contains bleeding.	Microvascular thrombosis and ischaemic organ injury.

12. Resolution and possible outcomes

12.1 Complete resolution

Resolution occurs when the cause is removed, the inflammatory mediators decline, neutrophils undergo apoptosis, macrophages clear debris and lymphatics drain oedema. Tissue architecture returns to normal when damage is limited.

12.2 Healing by fibrosis

Large tissue defects, fibrin-rich exudates, destruction of the extracellular matrix or non-regenerating tissues heal with collagen deposition. Scar restores strength but not normal function.

12.3 Abscess formation

Pyogenic organisms and neutrophils create a liquefied collection. Drainage and antibiotics may be required because the centre is poorly penetrated by immune cells and drugs.

12.4 Progression to chronic inflammation

Persistent infection, foreign bodies, autoimmune stimulation or unresolved necrosis sustain macrophages and lymphocytes. Repeated injury and repair produce fibrosis, angiogenesis and remodelling.

13. Systemic inflammation

13.1 Acute-phase response

IL-6 stimulates the liver to produce CRP, fibrinogen, serum amyloid A and hepcidin. TNF and IL-1 cause fever, anorexia, somnolence and leukocyte activation. Fibrinogen raises ESR and promotes rouleaux.

13.2 Leukocytosis patterns

Pattern	Common associations
Neutrophilia	Bacterial infection, stress, corticosteroids and tissue necrosis.
Lymphocytosis	Viral infection and some chronic infections.
Eosinophilia	Allergy, parasitic disease and drug reactions.
Monocytosis	Chronic inflammation and recovery from neutropenia.
Leukopenia	Severe sepsis, marrow failure, viral disease or overwhelming infection.

13.3 Sepsis and systemic inflammatory dysregulation

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Excess cytokines, endothelial injury, vasodilation, capillary leak, microthrombi and mitochondrial dysfunction impair tissue perfusion. Fever may be absent, especially in older or immunosuppressed patients. Treat suspected sepsis promptly with assessment, antimicrobials when indicated, source control and haemodynamic support according to current protocols.

14. Special patterns of inflammation

Pattern	Dominant fluid/cells	Typical examples
Serous	Watery, low-cell fluid.	Blister, mild pleuritis or viral serositis.
Fibrinous	Fibrin-rich exudate.	Fibrinous pericarditis or pleuritis.
Suppurative/purulent	Neutrophils, bacteria and necrotic debris.	Abscess, cellulitis and bacterial pneumonia.
Catarrhal	Mucus-rich exudate on mucosal surfaces.	Viral rhinitis or bronchitis.
Haemorrhagic	Red cells leak with severe vascular injury.	Some viral infections, necrotising infections and severe pancreatitis.
Granulomatous	Aggregates of activated macrophages and lymphocytes.	Tuberculosis, sarcoidosis and foreign-body reactions.

15. Emergency applications

• Anaphylaxis: mast-cell mediator release causes airway oedema, bronchospasm and vasodilation; give intramuscular adrenaline promptly and support airway/circulation.
• Sepsis: dysregulated inflammation causes hypotension, capillary leak and organ dysfunction; use early recognition, antimicrobials/source control and haemodynamic support.
• Acute asthma: leukotrienes, eosinophils and airway inflammation increase bronchoconstriction and mucus; treat bronchospasm and inflammation while monitoring fatigue.
• Trauma and burns: DAMPs produce sterile inflammation; control bleeding, perfusion, temperature and infection risk.
• Acute coronary or cerebral ischaemia: reperfusion can salvage tissue but also triggers inflammatory and oxidative injury.
• Autoimmune flare: identify organ-threatening inflammation, manage urgent complications and involve specialists rather than masking symptoms alone.

16. Applied cases

Case 1: Local cellulitis

Redness, warmth, swelling and pain reflect arteriolar dilation, exudate and leukocyte recruitment. Mark the border, assess systemic toxicity, look for abscess or necrotising infection, and treat according to local antimicrobial guidance. Rapid progression, pain out of proportion or shock changes the urgency.

Case 2: Acute pancreatitis

Enzymatic tissue injury activates macrophages, neutrophils and cytokines. Inflammation can become systemic, producing hypoxaemia, hypotension, renal failure and hypocalcaemia. Early supportive care and repeated assessment are essential.

Case 3: Anaphylaxis

IgE-mediated mast-cell activation releases histamine, tryptase, leukotrienes and prostaglandins. Rapid vasodilation, capillary leak and bronchospasm can be fatal. Intramuscular adrenaline is first-line; antihistamines and corticosteroids are adjuncts, not substitutes.

17. Common errors

• Inflammation equals infection: sterile infarction, trauma, crystals and autoimmune disease also inflame.
• No fever means no serious inflammation: older, immunosuppressed or shocked patients may be afebrile.
• CRP identifies the source: it indicates acute-phase activity, not a specific organism or organ.
• All inflammation should be suppressed: early suppression may impair microbial clearance; treat the cause and the dangerous physiology.
• Redness is always benign: rapidly spreading erythema with pain or toxicity may be necrotising infection.

18. Quick self-test

1. What are the five classic local signs?
   Answer: Redness, heat, swelling, pain and loss of function.
2. What is the difference between an exudate and a transudate?
   Answer: Exudate results from inflammatory permeability and is protein-rich; transudate results from hydrostatic/oncotic imbalance and is protein-poor.
3. Name two DAMPs.
   Answer: HMGB1, extracellular ATP, mitochondrial DNA, uric acid crystals or heat-shock proteins.
4. Which leukocyte dominates early acute inflammation?
   Answer: The neutrophil.
5. Give two possible outcomes of acute inflammation.
   Answer: Resolution, fibrosis, abscess formation or progression to chronic inflammation.
6. Why can inflammation damage healthy tissue?
   Answer: Activated leukocytes release ROS, proteases, cytokines and thrombotic mediators that can injure bystander cells.
7. What makes sepsis different from a contained local response?
   Answer: A dysregulated systemic host response causes organ dysfunction, perfusion failure and potentially shock.
8. What is the emergency priority in anaphylaxis?
   Answer: Immediate intramuscular adrenaline with airway and circulatory support.

19. Take-home summary

Selected references

• NCBI Bookshelf: Inflammation and Repair
• NCBI Bookshelf: Acute Inflammation
• NCBI Bookshelf: Chronic Inflammation
• NCBI Bookshelf: Sepsis and Septic Shock
• WHO: Clinical management of sepsis and septic shock

Educational note: This resource supports learning and clinical reasoning. Current local protocols, senior supervision and national guidelines take precedence in patient care.